LH 234.38 (+2.3%)
US50540R4092Medical Diagnostics & ResearchDiagnostics & Research

Laboratory Corp of America Holdings (LH) Competitor Comparison

We are evaluating the key criteria listed to compare Laboratory Corp of America Holdings (LH) against its competitors in the Diagnostics & Research industry.

Linearity 10 years - LH ranking 42 / 58

These are the competitors of Laboratory Corp of America Holdings in the industry Diagnostics & Research ranked by linearity 10 years
1. National Research NRC
63.27
2. Ortho Clinical Diagnostics Holdings OCDX
33.4
3. Neogen NEOG
33.04
4. Inotiv NOTV
25.51
5. Guardant Health GH
22.52
6. Illumina ILMN
16.13
7. Olink Holding OLK
8.11
8. Anixa Biosciences ANIX
6.31
9. Global Cord Blood CO
5.67
10. Bioventus BVS
5.61
11. Pacific Biosciences of California PACB
5.37
12. Sotera Health SHC
4.96
13. DarioHealth DRIO
4.86
14. Sera Prognostics SERA
4.28
15. Myriad Genetics MYGN
4.2
16. Fulgent Genetics FLGT
3.79
17. Syneos Health SYNH
3.71
18. Co-Diagnostics CODX
3.26
19. Qiagen QGEN
3.12
20. Enzo Biochem ENZ
3.02
21. NeoGenomics NEO
2.89
22. Psychemedics PMD
2.78
23. Twist Bioscience TWST
2.77
24. Aspira Womens Health AWH
2.28
25. Exagen XGN
2.2
26. Meridian Bioscience VIVO
2.1
27. MDxHealth MDXH
2.04
28. Biodesix BDSX
1.96
29. MaxCyte MXCT
1.9
30. Charles River Laboratories CRL
1.89
31. Personalis PSNL
1.88
32. CareDx CDNA
1.82
33. Prenetics Global PRE
1.79
34. bioAffinity Technologies BIAF
1.71
35. Organovo Holdings ONVO
1.66
36. Neuronetics STIM
1.62
37. Exact Sciences EXAS
1.61
38. Trinity Biotech TRIB
1.57
39. SeqLL SQL
1.42
40. Quest Diagnostics DGX
1.36
41. Interpace Biosciences IDXG
1.33
42. Laboratory Corp of America Holdings LH
1.31
43. DexCom DXCM
1.21
44. PerkinElmer PKI
1.15
45. Precipio PRPO
1.09
46. IQVIA Holdings IQV
0.98
47. Icon ICLR
0.97
48. Agilent Technologies A
0.89
49. IDEXX Laboratories IDXX
0.78
50. Waters WAT
0.67
51. Mettler-Toledo MTD
0.62
52. Thermo Fisher Scientific TMO
0.57
53. Danaher DHR
0.56
54. Heska HSKA
0.52
55. RadNet RDNT
0.4
56. Natera NTRA
0.4
57. Lantheus Holdings LNTH
0.39
58. Medpace Holdings MEDP
0.22

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.